Sectors
ACXP
Acurx Pharmaceuticals, Inc.
1.46
2 x 1.04
2 x 1.77
bid
ask
+
0.10
7.35%
2 @ 05:15 PM
1.45 -0.01 (0.68%)
| Ytd | -41.37% | |
| 1y | -85.40% |
1.37
day range
1.53
1.33
52 week range
66.50
| Open | 1.38 | Prev Close | 1.36 | Low | 1.37 | High | 1.53 | Mkt Cap | 6.27M |
| Vol | 69.63K | Avg Vol | 115.29K | EPS | -4.05 | P/E | N/A | Forward P/E | -0.56 |
| Beta | -2.05 | Short Ratio | 12.59 | Inst. Own | 11.96% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 1.79 | 200-d Avg | 3.25 | 1yr Est | 11.19 |
| Income Statement | |||
| Operating Expenses | 1.72M | ||
| Research and Development Expense | 341.47K | ||
| Selling, General and Administrative Expense | 1.37M | ||
| Operating Income | -1.72M | ||
| Net Income | -1.68M | ||
| Net Income Common Stock | -1.68M | ||
| Net Income Common Stock (USD) | -1.68M | ||
| Consolidated Income | -1.68M | ||
| Earnings per Basic Share | -0.62 | ||
| Earnings per Basic Share (USD) | -0.62 | ||
| Earnings per Diluted Share | -0.62 | ||
| Earning Before Interest & Taxes (EBIT) | -1.68M | ||
| Earning Before Interest & Taxes (USD) | -1.68M | ||
| Weighted Average Shares | 2.72M | ||
| Weighted Average Shares Diluted | 2.72M | ||
| Balance Sheet | |||
| Cash and Equivalents | 9.25M | ||
| Cash and Equivalents (USD) | 9.25M | ||
| Trade and Non-Trade Receivables | 56.31K | ||
| Current Assets | 9.54M | ||
| Total Assets | 9.54M | ||
| Current Liabilities | 2.53M | ||
| Total Liabilities | 2.53M | ||
| Accumulated Retained Earnings (Deficit) | -76.97M | ||
| Shareholders Equity | 7.01M | ||
| Shareholders Equity (USD) | 7.01M | ||
| Trade and Non-Trade Payables | 2.53M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 3.11M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 1.70M | ||
| Issuance (Purchase) of Equity Shares | 3.11M | ||
| Net Cash Flow from Operations | -1.41M | ||
| Share Based Compensation | 258.29K | ||